Shiphrah Biomedical Inc.
Founded in Toronto in early 2019, we are a multidisciplinary team of professionals dedicated to challenging the status quo in pregnancy.
We are solving one of the biggest challenges in pregnancy: sleep.
We are also solving one of the biggest challenges in sleep: pregnancy.
Through the combination of artificial intelligence, science, medicine, engineering, and innovation, we are committed to aiming the trajectory of improvement steeper than ever, transforming today’s limits into tomorrow’s possibilities.
Research participants recruited
Research participants screened
Nights of study
Images extracted for AI models
Data points collected
Our track record
Eight years in the making, our first medical device is set to launch very soon.
Stay tuned because we have much more in our pipeline!
Past, present, future – we are a company built on research.
Through our work and that of our collaborators, we are leading our field by contributing knowledge and making discoveries.
We follow a holistic approach to development.
We design and build solutions on the basis of clinical evidence while simultaneously meeting the user’s needs.
Have a great MedTech idea but need help?
Consult our multidisciplinary team to bring your device from ideation through commercialization.
Awards & Memberships
Since 2013, our team has won over $330,000 of R&D funding.
More recently, we have become an active member of the Toronto MedTech startup community.
Research ethics govern the standards of conduct for scientific researchers. It is important to adhere to ethical principles in order to protect the dignity, rights and welfare of research participants.
–World Health Organization
For every clinical study that we have conducted, we have received review, approval, and oversight by an approved institutional ethics committee.
In most countries, medical devices are federally regulated in order to ensure compliance, safety, and efficacy of these devices.
Our research involves investigation-stage medical devices, which, in some countries, requires regulatory oversight. We and our collaborators, not without great effort, have always been found to be in substantial compliance with the respective regulatory standards in the countries in which our devices have been clinically tested.